Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention
- PMID: 15347674
- DOI: 10.1074/jbc.M408583200
Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention
Abstract
Histone deacetylase 6 (HDAC6) contains tandem catalytic domains and a ubiquitin-binding zinc finger and displays deacetylase activity toward acetylated microtubules. Here we show that unlike its orthologs from Caenorhabditis elegans, Drosophila, and mouse, human HDAC6 possesses a tetradecapeptide repeat domain located between the second deacetylase domain and the C-terminal ubiquitin-binding motif. Related to this structural difference, the cytoplasmic localization of human, but not murine, HDAC6 is resistant to treatment with leptomycin B (LMB). Although it is dispensable for the deacetylase and ubiquitin binding activities of human HDAC6, the tetradecapeptide repeat domain displays acetyl-microtubule targeting ability. Moreover, it forms a unique structure and is required for the LMB-resistant cytoplasmic localization of human HDAC6. Besides the tetradecapeptide repeat domain, human HDAC6 possesses two LMB-sensitive nuclear export signals and a nuclear localization signal. These results thus indicate that the cytoplasmic localization for murine and human HDAC6 proteins is differentially regulated and suggest that the tetradecapeptide repeat domain serves as an important sequence element to stably retain human HDAC6 in the cytoplasm.
Similar articles
-
Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation.J Biol Chem. 2012 Aug 17;287(34):29168-74. doi: 10.1074/jbc.M112.371120. Epub 2012 Jul 9. J Biol Chem. 2012. PMID: 22778253 Free PMC article.
-
Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation.Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4389-94. doi: 10.1073/pnas.0430973100. Epub 2003 Apr 3. Proc Natl Acad Sci U S A. 2003. PMID: 12677000 Free PMC article.
-
Molecular cloning and characterization of a novel histone deacetylase HDAC10.J Biol Chem. 2002 Feb 1;277(5):3350-6. doi: 10.1074/jbc.M109861200. Epub 2001 Nov 28. J Biol Chem. 2002. PMID: 11726666
-
HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination.Oncogene. 2007 Aug 13;26(37):5468-76. doi: 10.1038/sj.onc.1210614. Oncogene. 2007. PMID: 17694087 Review.
-
New insights into the non-enzymatic function of HDAC6.Biomed Pharmacother. 2023 May;161:114438. doi: 10.1016/j.biopha.2023.114438. Epub 2023 Mar 9. Biomed Pharmacother. 2023. PMID: 37002569 Review.
Cited by
-
Histone deacetylase 6 as a novel promising target to treat cardiovascular disease.Cancer Innov. 2024 May 7;3(3):e114. doi: 10.1002/cai2.114. eCollection 2024 Jun. Cancer Innov. 2024. PMID: 38947757 Free PMC article. Review.
-
Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity.Mol Biol Cell. 2006 Aug;17(8):3435-45. doi: 10.1091/mbc.e06-01-0008. Epub 2006 May 31. Mol Biol Cell. 2006. PMID: 16738306 Free PMC article.
-
Function of histone deacetylase 6 as a cofactor of nuclear receptor coregulator LCoR.J Biol Chem. 2009 Oct 30;284(44):30264-74. doi: 10.1074/jbc.M109.045526. Epub 2009 Sep 10. J Biol Chem. 2009. PMID: 19744931 Free PMC article.
-
Coordinated regulation of Rel expression by MAP3K4, CBP, and HDAC6 controls phenotypic switching.Commun Biol. 2020 Aug 28;3(1):475. doi: 10.1038/s42003-020-01200-z. Commun Biol. 2020. PMID: 32859943 Free PMC article.
-
Histone deacetylase 6 (HDAC6) is an essential modifier of glucocorticoid-induced hepatic gluconeogenesis.Diabetes. 2012 Feb;61(2):513-23. doi: 10.2337/db11-0313. Epub 2011 Dec 30. Diabetes. 2012. PMID: 22210316 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources